Kestra Medical Technologies, Ltd. (KMTS) Cash Flow Statement
Kestra Medical Technologies, Ltd. (KMTS) generated -$87.7M of operating cash flow over the twelve months to 2026-07-31, spent $35.1M on capital expenditure and had free cash flow of -$122.8M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
KMTSKestra Medical Technologies, Ltd.Follow KMTS — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Dec, in 48 days
| Line | FY2024 Apr 24 | FY2025 Apr 25 | FY2026 Apr 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|
| Operating cash flow | -72.2 | -77.6 | -81.7 | -87.7 | |
| Capital expenditure | 12.2 | 22.9 | 34.9 | -35.1 | |
| Free cash flow | -84.5 | -100.5 | -116.6 | -122.8 | |
| Stock-based compensation | 1.5 | 24.3 | 33.6 | — |
USD millions · SEC XBRL
Kestra Medical Technologies, Ltd. — questions
- What is Kestra Medical Technologies, Ltd.'s operating cash flow?
- -$87.7M over the twelve months to 2026-07-31.
- How much does Kestra Medical Technologies, Ltd. spend on capital expenditure?
- $35.1M over the twelve months to 2026-07-31.
- What is Kestra Medical Technologies, Ltd.'s free cash flow?
- -$122.8M over the twelve months to 2026-07-31: operating cash flow minus capital expenditure.
Every figure on this page comes from Kestra Medical Technologies, Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.